Oftalmoloxía
Servicio
Publicacións nas que colabora con Miguel González Barcia (19)
2024
-
Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study
International Journal of Molecular Sciences, Vol. 25, Núm. 18
-
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
International Journal of Pharmaceutics, Vol. 662
-
The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration
Pharmaceutics, Vol. 16, Núm. 1
2023
-
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration
Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34
-
Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review
Pharmaceutics, Vol. 15, Núm. 3
2022
-
Microbiome in Immune-Mediated Uveitis
International Journal of Molecular Sciences, Vol. 23, Núm. 13
2021
-
Base preclínica de sistemas lipídicos nanoestructurados (NLC) cargados con bevacizumab: diseño, desarrollo y caracterización fisicoquímica
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 87-89
2020
-
Características clínicas, manejo y resultados de los pacientes con endoftalmitis estéril asociados con la inyección intravítrea de factores de crecimiento endotelial antivascular
Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 5, pp. 211-216
-
Recent research in ocular cystinosis: Drug delivery systems, cysteamine detection methods and future perspectives
Pharmaceutics, Vol. 12, Núm. 12, pp. 1-21
2019
-
Therapeutic approach in fungal keratitis
Mycotic Keratitis (CRC Press), pp. 189-216
2018
-
Preclinical characterization and clinical evaluation of tacrolimus eye drops
European Journal of Pharmaceutical Sciences, Vol. 120, pp. 152-161
-
Review of intraocular pharmacokinetics of anti-infectives commonly used in the treatment of infectious endophthalmitis
Pharmaceutics, Vol. 10, Núm. 2
2017
-
Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging
International Journal of Pharmaceutics, Vol. 528, Núm. 1-2, pp. 714-722
-
In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops
Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 3, pp. 202-209
-
In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323
-
Preclinical PET study of intravitreal injections
Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851
2016
-
Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the hospital pharmacy departments
Farmacia Hospitalaria, Vol. 40, Núm. 5, pp. 352-370
2015
-
In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 94, pp. 342-351
-
Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention
International Journal of Pharmaceutics, Vol. 495, Núm. 2, pp. 680-691